Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-weekly etanercept in polyarticular-course juvenile idiopathic arthritis
2007-000255-34Phase 3Completed
- Sponsor
- Asklepios Klinik Sankt Augustin
- Start
- May 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of etanercept in juvenile idiopathic arthritis (JIA), sponsored by Asklepios Klinik Sankt Augustin. Primary endpoints: ACR Pediatric 30 response, Number of swollen joints and 7 more. Started May 2007; status: completed.
02
Drugs
etanercept
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2007-000255-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000255-34.